Home / Resource Library / Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naive CLL/SLL

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naive CLL/SLL

Study investigated hypertension in patients with CLL treated with acalabrutinib and ibrutinib.